Author:
Zewail-Foote Maha,Li Ven-Shun,Kohn Harold,Bearss David,Guzman Mary,Hurley Laurence H
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,Molecular Medicine,General Medicine,Biochemistry
Reference48 articles.
1. Ecteinascidins 729, 743, 745, 759A, 759B, and 770: potent antitumor agents from the Caribbean tunicate Ecteinascidia turbinate;Rinehart;J. Org. Chem.,2000
2. Progress in the acquisition of new marine-derived anticancer compounds: development of the ecteinascidin-743 (Et-743);Jimeno;Drugs Future,1996
3. Ecteinascidins: putative biosynthetic precursors and absolute stereochemistry;Sakai;J. Am. Chem. Soc.,1996
4. Phase I clinical and pharmacokinetic (PK) study of ecteinascidin-743 (Et-743) given as a one hour infusion every 21 days;Bowman;Ann. Oncol.,1998
5. A phase I and pharmacokinetic study of ET-743, a novel DNA minor groove binder of marine origin, administered as a 1-hour infusion daily ×5 days;Villalona-Calero;Ann. Oncol.,1998
Cited by
78 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献